Mark J Ansermino

November 25, 2024

Mark J Ansermino

Professor

BC Children’s Hospital

Faculty Bio

I am a Professor in the Department of Anesthesiology, Pharmacology & Therapeutics at the University of British Columbia (UBC) and the Executive Medical Director for Global Health at British Columbia’s Children’s Hospital, Vancouver Canada. I was a Michael Smith Foundation for Health Research Scholar and the Brockhouse Canada Prize for Interdisciplinary Research winner in 2011. I lead an interdisciplinary research team of engineers and clinicians who develop and evaluate novel technical solutions (devices and smart applications) to improve women’s and children’s health outcomes worldwide. As a team, we combine science and engineering to create cutting-edge technology that uses clinical data, automation and smart physical sensors to improve outcomes. Our focus is on extracting important data features from devices and using predictive and machine learning models based on large population datasets to provide accessible decision-making support at all levels of healthcare in every area of the world.

Social Media / Lab or Research Website

Website: https://www.bcchr.ca/mansermino

Social Media: https://www.linkedin.com/in/markansermino/

Research Interests

Sepsis, Digital Health, Global Health, AI in Health

Research Theme(s)

Clinical Outcomes and Patient Safety, Equity in Medicine, Pediatric anesthesiology, Peri-operative technology integration

Publication Link(s)

Clinical Interests

Services

Teaching

Khaled S. Abdelrahman

November 8, 2024

Khaled S. Abdelrahman

Assistant Professor

Member, Djavad Mowafaghian Centre for Brain Health

Email: khaled.abdelrahman@ubc.ca

Faculty Bio

Dr. Khaled Abdelrahman holds a BSc in Pharmaceutical Sciences and an MSc in Pharmacology from Alexandria University. He earned his PhD in 2015 from the University of Calgary, where he researched the molecular basis of altered cerebrovascular function in type 2 diabetes. Following his PhD, he joined the University of Ottawa’s Departments of Cellular & Molecular Medicine and Neuroscience to investigate novel G protein-coupled receptor (GPCR) candidates for pharmacological targeting to slow the progression of Alzheimer’s and Huntington’s diseases. During his postdoctoral tenure, Dr. Abdelrahman was supported by prestigious salary awards from Canadian Institutes of Health Research and Alberta Innovates. He also received the Canadian Society of Pharmacology and Therapeutics Postdoctoral Award and several young investigator awards from the American Society for Pharmacology and Experimental Therapeutics. With over 12 years of clinical experience, he is a registered pharmacist dedicated to providing patient care. Currently, Dr. Abdelrahman is an Assistant Professor in the Department of Anesthesiology, Pharmacology, and Therapeutics at the University of British Columbia (UBC) and a full member of the Djavad Mowafaghian Centre for Brain Health. Since joining UBC, he has been awarded the Michael Smith Health Research BC Health Investigator Award. His research program is supported by grants from the Alzheimer’s Society of Canada and the Canadian Institutes of Health Research.

Social Media / Lab or Research Website

Website: https://ksaresearch.med.ubc.ca/

Social Media: https://x.com/K_S_Abdelrahman

Research Interests

GPCRs, Neurodegeneration, Neurovascular Coupling, Cerebral Blood Flow

Research Theme(s)

Evidence-based medicine and knowledge translation, Neurosciences and anesthesiology

Publication Link(s)

PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Khaled+abd-elrahman&sort=date

Google Scholar: https://scholar.google.ca/citations?user=mn17mc0AAAAJ&hl=en

Clinical Interests

Services

Teaching

PCTH_V 400

PCTH_V 448E

PCTH_V 548F

NRSC_V 551

Flynn O’Connor

November 7, 2024

Name:

Flynn O’Connor

Bio

Dr. Khaled Abdelrahman holds BSc (Pharmaceutical Sciences) and MSc (Pharmacology) from Alexandria University. He received his PhD in 2015 from the University Calgary where he studied the molecular basis underlying altered cerebrovascular function in type 2 diabetes. He then joined the Departments of Cellular & Molecular Medicine and Neuroscience at the University of Ottawa to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically to slow the progression of Alzheimer’s and Huntington’s’ diseases. His research was supported by prestigious salary awards offered by Canadian institutes for health research and Alberta innovates. He is also the recipient of the Canadian Society of Pharmacology and Therapeutics Postdoctoral award and many young investigator awards from the American Society for Pharmacology and Experimental Therapeutics. He is a Registered Pharmacist with over 12 years of clinical expertise in providing patient care. He is currently an Assistant Professor in the Department of Anesthesiology, Pharmacology and Therapeutics in the Faculty of Medicine at the University of British Columbia and a full member of the Djavad Mowafaghian Centre for Brain Health.

General Research Interests

Neurosciences and anesthesiology

Research Interests

Dr. Khaled Abdelrahman’s lab focuses on exploring the contribution of some GPCRs to the impaired neurovascular coupling and cerebral blood flow autoregulation in Alzheimer’s disease mouse models. His lab employs in vitro, ex vivo and in vivo approaches to identify novel GPCR candidates that can be targeted pharmacologically to correct neurovascular coupling and slow neurodegeneration. His lab is also interested in studying what aspects of GPCR signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area of neurodegenerative diseases.

Rich Tape

November 7, 2024

Name:

Rich Tape

Bio

Dr. Ambasta received her BSc. (2009) in Biological Sciences and her medical degree (2012), both from the University of Calgary. She subsequently completed a 5-year residency program in General Internal Medicine at the University of Calgary, followed by a Masters in Public Health at the Harvard T.H. Chan School of Public Health with a focus on Clinical Effectiveness. During her Master’s program, Dr. Ambasta worked to describe and manage the problem of over-utilization of laboratory tests in hospitalized patients. She began her clinical appointment with University of Calgary in 2017 where she complemented her clinical practice as a General Internal Medicine physician with ongoing research in healthcare quality and patient safety. Her research work in the area of low-value laboratory testing was funded by Alberta Health Services, Choosing Wisely Alberta, Canadian Society of Internal Medicine, Alberta Health Services, and Canadian Institutes of Health Research. She began her academic appointment with University of British Columbia in 2022 as an Assistant Professor in the Department of Anesthesia, Pharmacology, and Therapeutics. She is a member of the Therapeutics Initiative where is building a research program on reduction of low-value diagnostics and therapeutic services in health systems.

General Research Interests

Clinical Outcomes and Patient Safety, Evidence-based medicine and knowledge translation, Pharmacoepidemiology

Research Interests

Her ongoing research projects include: implementation of a multi-modal intervention bundle to reduce low-value laboratory testing across hospitals in Alberta and British Columbia, collaboration with a patient and family advisory council to engage patients with reduction of low-value use of health care resources, and describing linkages between low value use of diagnostic testing and therapeutic use in healthcare systems.

Teresa Skelton

November 7, 2024

Dr.

Teresa Skelton

Academic Rank:

Clinical Associate Professor

Hospital Site(s):

Service

OpenClose

Service

Teaching

OpenClose

Teaching

Kaixuan Kate Liu

November 4, 2024

Dr.

Kaixuan Kate Liu

Academic Rank:

Clinical Instructor

Hospital Site(s):

Service

OpenClose

Service

Teaching

OpenClose

Teaching

Kamal Sidhu

November 4, 2024

Dr.

Kamal Sidhu

Academic Rank:

Clinical Instructor

Hospital Site(s):

Service

OpenClose

Service

Teaching

OpenClose